Can thymosin β4 and soluble CD163 be used as biomarkers of the prognosis in acute on chronic liver failure?

J Gastrointestin Liver Dis. 2022 Mar 20;31(1):143-145. doi: 10.15403/jgld-4161.

¹ Department of Gastroenterology and Hepatology, Max Super Specialty Hospital, Vaishali, Ghaziabad, India. . [email protected].
² Department of Medicine, Maulana Azad Medical College, New Delhi, India; Department of Medicine, Allegheny Health Network, Pittsburgh, Pennsylvania, US. [email protected].
³ Department of Medicine, Maulana Azad Medical College, New Delhi, India. [email protected].
⁴ Department of Gastroenterology and Hepatology, Max Super Specialty Hospital, Vaishali, Ghaziabad, India. [email protected].

No abstract available

Publication types